SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?


To: SAM-DAN who wrote (937)5/12/1998 11:22:00 AM
From: Harold Lehman  Read Replies (1) | Respond to of 1501
 
I do not want to sound critical, but the rest of us don't have any idea of who you know, what type of position they hold, and what type of place they work at. In other words it's impossible to ascertain whether your source has credibility.

Also, if Rothchilds or Goldman Sachs were doing any buying I just cannot believe that any of us would be in a position to know about it.It may seem very plausible, even highly probable, but I think there's no definitive smoking gun.

In fact I have an alternative scenario. Yesterday, the day of Inflazyme's greatest gain in a long time, was the first day that the new CEO "was in the office", according the the girl who answered the phone over there. Maybe it's a positive affirmation of the new CEO's actual presence.

I wasn't able to get through to Michael Liggett, the CFO/IR person, this morning, but when I do I want to ask him whether the tb diagnostic test kits have arrived yet.